from Reuters: Health News https://ift.tt/2IpDCex
Pfizer's biosimilar of Amgen, J&J's anemia treatments gets FDA nod
(Reuters) - Pfizer Inc's Retacrit was approved by U.S. health regulators as a biosimilar to current anemia treatments from Amgen Inc and Johnson & Johnson on Tuesday, setting it up to compete against more established brands.
from Reuters: Health News https://ift.tt/2IpDCex
from Reuters: Health News https://ift.tt/2IpDCex
Subscribe to:
Post Comments (Atom)
-
The German cabinet will hold a secret session on Wednesday to discuss safeguard measures regarding the possible participation of China's...
-
Stocks poised for another day of gains Equity markets look to add to the gains from the prior session as investor concerns about the fu...
-
By LIAM STACK from NYT Magazine https://ift.tt/2FNPp6k
No comments:
Post a Comment